These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17683652)

  • 1. Biology of bone metastases: causes and consequences.
    Harvey HA; Cream Lv
    Clin Breast Cancer; 2007 Jul; 7 Suppl 1():S7-S13. PubMed ID: 17683652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model.
    Lee YP; Schwarz EM; Davies M; Jo M; Gates J; Zhang X; Wu J; Lieberman JR
    Cancer Res; 2002 Oct; 62(19):5564-70. PubMed ID: 12359769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.
    Guise TA; Mohammad KS; Clines G; Stebbins EG; Wong DH; Higgins LS; Vessella R; Corey E; Padalecki S; Suva L; Chirgwin JM
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6213s-6216s. PubMed ID: 17062703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of breast cancer metastases to bone.
    Guise TA; Kozlow WM; Heras-Herzig A; Padalecki SS; Yin JJ; Chirgwin JM
    Clin Breast Cancer; 2005 Feb; 5 Suppl(2):S46-53. PubMed ID: 15807924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bone-anabolic agents in the treatment of breast cancer bone metastases.
    Suvannasankha A; Chirgwin JM
    Breast Cancer Res; 2014; 16(6):484. PubMed ID: 25757219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
    Sterling JA; Edwards JR; Martin TJ; Mundy GR
    Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.
    Trinkaus M; Ooi WS; Amir E; Popovic S; Kalina M; Kahn H; Singh G; Gainford MC; Clemons M
    Oncol Rep; 2009 May; 21(5):1153-9. PubMed ID: 19360288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteolytic and osteoblastic bone metastases: two extremes of the same spectrum?
    Ortiz A; Lin SH
    Recent Results Cancer Res; 2012; 192():225-33. PubMed ID: 22307378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of osteolytic bone destruction.
    Mundy GR
    Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.
    Kupisiewicz K
    Dan Med Bull; 2011 May; 58(5):B4277. PubMed ID: 21535989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention.
    Lipton A
    J Support Oncol; 2004; 2(3):205-13; discussion 213-4, 216-7, 219-20. PubMed ID: 15328823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblasts are "educated" by crosstalk with metastatic breast cancer cells in the bone tumor microenvironment.
    Kolb AD; Shupp AB; Mukhopadhyay D; Marini FC; Bussard KM
    Breast Cancer Res; 2019 Feb; 21(1):31. PubMed ID: 30813947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone resorption and bone metastasis risk.
    Mathis KM; Sturgeon KM; Winkels RM; Wiskemann J; De Souza MJ; Schmitz KH
    Med Hypotheses; 2018 Sep; 118():36-41. PubMed ID: 30037612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonates in the treatment of metastatic breast cancer.
    Body JJ
    J Mammary Gland Biol Neoplasia; 2001 Oct; 6(4):477-85. PubMed ID: 12013536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimising treatment of bone metastases by Aredia(TM) and Zometa(TM).
    Coleman RE
    Breast Cancer; 2000; 7(4):361-9. PubMed ID: 11114866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future treatment of bone metastases.
    Lipton A
    Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6305s-6308s. PubMed ID: 17062719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiology of bone metastases in urologic carcinomas].
    Sauer G; Barth TF; Möller P
    Urologe A; 2007 Aug; 46(8):888-90. PubMed ID: 17632696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Is Breast in the Bone?
    Shemanko CS; Cong Y; Forsyth A
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of osteolytic bone metastases in breast carcinoma.
    Käkönen SM; Mundy GR
    Cancer; 2003 Feb; 97(3 Suppl):834-9. PubMed ID: 12548583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.